Literature DB >> 8821183

A population-based study of the coverage of cancer patients by hospice services.

R Hunt1, K McCaul.   

Abstract

The aims were to determine the proportion of terminal cancer patients in South Australia who had involvement with a programme of hospice care, to identify the predictors of hospice involvement, and to consider the influence of hospice services, along with other variables, on the place of death. A file of patients of the State's hospice services who died in 1990 was compiled and linked to the population-based Central Cancer Register. We found that 1561 (56%) of the 2800 cancer patients who died in 1990 had care from a hospice service. Patients were less likely to be involved with a hospice service if they were 80 years or older, lived in a rural region, or had a haematological malignancy, and more likely to have hospice care if they had a survival time of more than six months, or were born in the UK or Europe. Patients of hospice services were more likely than other patients to die at home or in an inpatient hospice, and less likely to die in a nursing home or private hospital. A range of other factors were also found to be associated with place of death. We conclude that there has been a rapid acceptance of hospice care in South Australia, with a majority of the target population of cancer patients covered by services. Epidemiological research methods are useful for identifying gaps in the provision of care, and for determining the impact of various factors on where people die. This research is, therefore, important for the formulation and evaluation of policy for the delivery of terminal care.

Entities:  

Mesh:

Year:  1996        PMID: 8821183     DOI: 10.1177/026921639601000103

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  16 in total

1.  A population-based study on the specific locations of cancer deaths in Taiwan, 1997-2003.

Authors:  Herng-Ching Lin; Chia-Chin Lin
Journal:  Support Care Cancer       Date:  2007-01-05       Impact factor: 3.603

2.  Proportion of cancer deaths occurring in hospital, Canada, 1994-2000.

Authors:  C Ineke Neutel; Michelle L Bishop; Samantha D Harper; Leslie A Gaudette
Journal:  Can J Public Health       Date:  2005 Jul-Aug

Review 3.  Factors influencing death at home in terminally ill patients with cancer: systematic review.

Authors:  Barbara Gomes; Irene J Higginson
Journal:  BMJ       Date:  2006-02-08

4.  Where a cancer patient dies: the effect of rural residency.

Authors:  Frederick Burge; Beverley Lawson; Grace Johnston
Journal:  J Rural Health       Date:  2005       Impact factor: 4.333

Review 5.  End-of-life care--what do cancer patients want?

Authors:  Shaheen A Khan; Barbara Gomes; Irene J Higginson
Journal:  Nat Rev Clin Oncol       Date:  2013-11-26       Impact factor: 66.675

6.  Development of a brief survey to measure nursing home residents' perceptions of pain management.

Authors:  Joan M Teno; David Dosa; Therese Rochon; Virginia Casey; Vincent Mor
Journal:  J Pain Symptom Manage       Date:  2008-06-17       Impact factor: 3.612

7.  Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy.

Authors:  Debra A Howell; Eve Roman; Helen Cox; Alexandra G Smith; Russell Patmore; Anne C Garry; Martin R Howard
Journal:  BMC Palliat Care       Date:  2010-06-01       Impact factor: 3.234

8.  Identifying potential need for cancer palliation in Nova Scotia.

Authors:  G M Johnston; L Gibbons; F I Burge; R A Dewar; I Cummings; I G Levy
Journal:  CMAJ       Date:  1998-06-30       Impact factor: 8.262

9.  Where do patients with cancer die in Belfast?

Authors:  D Davison; G Johnston; P Reilly; M Stevenson
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

10.  Predictors of dying at home for patients receiving nursing services in Japan: A retrospective study comparing cancer and non-cancer deaths.

Authors:  Sumie Ikezaki; Naoki Ikegami
Journal:  BMC Palliat Care       Date:  2011-03-03       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.